Both in Biotechnology
Allogene Therapeutics vs Eikon Therapeutics
Over the past year ALLO returned −33.1% and EIKN returned −62.1%; their daily moves had a correlation of 0.18.
ALLO −33.1% EIKN −62.1%Growth of $1, one year, split-adjusted
| Metric | ALLO | EIKN |
|---|---|---|
| Price | $1.09 | $5.68 |
| Market cap | $376.6M | $307.7M |
| Today | −7.63% | +6.97% |
| 1 month | −27.3% | −22.5% |
| 6 months | −51.8% | −44.7% |
| Year to date | −20.4% | — |
| 1 year | −9.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −919.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 81.2× | — |
| Net cash | $332.6M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.0% | 100.5% |
| Short % of float | 19.4% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).